Page 125 - GPD-4-2
P. 125

Gene & Protein in Disease                                             Pediatric glioma circadian clock genes



            the authors upon request.                             doi: 10.3389/fonc.2023.1223208

            References                                         13.  Sharma VP, Anderson NT, Geusz ME. Circadian properties
                                                                  of cancer stem cells in glioma cell cultures and tumorspheres.
            1.   Aronson BD, Bell-Pedersen D, Block GD, et al. Circadian   Cancer Lett. 2014;345(1):65-74.
               rhythms. Brain Res Brain Res Rev. 1993;18(3):315-333.
                                                                  doi: 10.1016/j.canlet.2013.11.009
               doi: 10.1016/0165-0173(93)90015-r
                                                               14.  Fujioka A, Takashima N, Shigeyoshi Y. Circadian rhythm
            2.   Moore RY, Speh JC, Leak RK. Suprachiasmatic nucleus   generation in a glioma cell line.  Biochem Biophys Res
               organization. Cell Tissue Res. 2002;309(1):89-98.  Commun. 2006;346(1):169-174.
               doi: 10.1007/s00441-002-0575-2                     doi: 10.1016/j.bbrc.2006.05.094
            3.   Hastings M, O’Neill JS, Maywood ES. Circadian clocks:   15.  Firdous S, Ghosh A, Saha S. BCSCdb: A  database of
               Regulators  of  endocrine  and  metabolic  rhythms.   biomarkers of cancer stem cells.  Database (Oxford).
               J Endocrinol. 2007;195(2):187-198.                 2022;2022:baac082.
               doi: 10.1677/JOE-07-0378                           doi: 10.1093/database/baac082
            4.   Sompol P, Liu X, Baba K,  et al. N-acetylserotonin   16.  Hambardzumyan  D,  Bergers  G.  Glioblastoma:  Defining
               promotes hippocampal neuroprogenitor cell proliferation   tumor niches. Trends Cancer. 2015;1(4):252-265.
               in  sleep-deprived  mice.  Proc Natl Acad Sci U S A.
               2011;108(21):8844-8849.                            doi: 10.1016/j.trecan.2015.10.009
                                                               17.  Hrushesky WJ, Lester B, Lannin D. Circadian coordination
               doi: 10.1073/pnas.1105114108
                                                                  of cancer growth and metastatic spread.  Int J Cancer.
            5.   Wang L, Wang C, Choi WS. Use of melatonin in cancer   1999;83(3):365-373.
               treatment: Where are we? Int J Mol Sci. 2022;23(7):3779.
                                                               18.  Filipski E, King VM, Li X, et al. Host circadian clock as a
               doi: 10.3390/ijms23073779                          control point in tumor progression. J  Natl Cancer Inst.
            6.   Sulli  G,  Lam  MTY,  Panda  S. Interplay between  circadian   2002;94(9):690-697.
               clock and cancer: New frontiers for cancer treatment. Trends   19.  Wang Z, Su G, Dai Z, et al. Circadian clock genes promote
               Cancer. 2019;5(8):475-494.                         glioma progression by affecting tumour immune infiltration
               doi: 10.1016/j.trecan.2019.07.002                  and tumour cell proliferation. Cell Prolif. 2021;54(3):e12988.
            7.   Ruben MD, Wu G, Smith DF, et al. A database of tissue-     doi: 10.1111/cpr.12988
               specific rhythmically expressed human genes has potential   20.  Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM,
               applications in circadian medicine.  Sci Transl Med.   Weaver DR. Differential functions of mPer1, mPer2,
               2018;10(458):eaat8806.                             and mPer3 in the SCN circadian clock.  Neuron.
               doi: 10.1126/scitranslmed.aat8806                  2001;30(2):525-536.
            8.   Takahashi JS. Molecular architecture of the circadian clock   21.  Benna C, Helfrich-Forster C, Rajendran S,  et al. Genetic
               in mammals. In: Sassone-Corsi P, Christen Y, editors. A Time   variation of clock genes and cancer risk: A field synopsis and
               for Metabolism and Hormones. Cham: Springer; 2016.  meta-analysis. Oncotarget. 2017;8(14):23978-23995.
            9.   Dong Z, Zhang G, Qu M, et al. Targeting glioblastoma stem      doi: 10.18632/oncotarget.15074
               cells through disruption of the circadian clock.  Cancer   22.  De La Cruz Minyety J, Shuboni-Mulligan DD, Briceno N,
               Discov. 2019;9(11):1556-1573.                      et al. Association of circadian clock gene expression with
               doi: 10.1158/2159-8290.CD-19-0215                  glioma  tumor  microenvironment  and  patient  survival.
                                                                  Cancers (Basel). 2021;13(11).
            10.  Geusz ME, Malik A, De A. Insights into oncogenesis from
               circadian timing in cancer stem cells. Crit Rev Oncog.      doi: 10.3390/cancers13112756
               2021;26(4):1-17.                                23.  Chen K, Wang Y, Li D, et al. Biological clock regulation by the
               doi: 10.1615/CritRevOncog.2021041960               PER gene family: A new perspective on tumor development.
                                                                  Front Cell Dev Biol. 2024;12:1332506.
            11.  Gonzalez-Aponte MF, Damato AR, Simon T,  et  al. Daily
               glucocorticoids promote glioblastoma growth and circadian      doi: 10.3389/fcell.2024.1332506
               synchrony to the host. Cancer Cell. 2025;43(1):144-160.
                                                               24.  Yang J, Antin P, Berx G, et al. Guidelines and definitions for
               doi: 10.1016/j.ccell.2024.11.012                   research on epithelial-mesenchymal transition. Nat Rev Mol
                                                                  Cell Biol. 2020;21(6):341-352.
            12.  Pan Y, van der Watt PJ, Kay SA. E-box binding transcription
               factors in cancer. Front Oncol. 2023;13:1223208.     doi: 10.1038/s41580-020-0237-9


            Volume 4 Issue 2 (2025)                         19                               doi: 10.36922/gpd.4112
   120   121   122   123   124   125   126   127   128   129   130